volume 27, issue 2, P359-377 2013
DOI: 10.1016/j.idc.2013.02.012
View full text
|
|
Share

Abstract: Intestinal and multivisceral transplantation has become an effective treatment option for patients with intestinal failure. More potent immunosuppressive therapy has resulted in a decreased incidence of acute rejection and has improved patient survival. However, infectious complications can cause significant morbidity both before and after transplantation. In comparison with other solid organ transplant recipients, these patients experience higher rates of acute allograft rejection, thus requiring higher level…

expand abstract